AstraZeneca to build new Virginia plant as it re-hashes other U.S. investment plans
AstraZeneca to build new Virginia plant as it re-hashes other U.S. investment plans
AstraZeneca will invest US$50bn in the US to expand manufacturing and research
AstraZeneca shares show signs of life after successful trials of hypertension drug
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - CNBC
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year. https://t.co/b5hOwTxWaU https://t.co/Wq5EsZGLK5
AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition
221.9BUSD
Jenis
Common Stock
Menukarkan
PINK
Kode mata uang
USD
Nama Mata Uang
US Dollar
Nama negara
USA
ISO Negara
US
ADALAH
GB0009895292
CUSIP
-
Sektor
Healthcare
Industri
Drug Manufacturers - General
Akhir Tahun Anggaran
December
tanggal IPO
-
Diperbarui Pada
-
Rasio PE
28.55
Rasio PEG
0.95
Nilai buku
26.48
Pembagian Dividen
3.1
Hasil Dividen
2.22%
Bagi Hasil
4.97
Target Harga Wall Street
-
Estimasi EPS Tahun Ini
-
Estimasi EPS Tahun Depan
-
Perkiraan EPS Kuartal Saat Ini
0
Estimasi EPS Kuartal Berikutnya
0
Kuartal Terbaru
-
Pendapatan TTM
54,982,000,640
TTM Laba Kotor
45,328,998,400
EBITDA
18,276,999,168
Margin Keuntungan
14.14%
Pengembalian Aset TTM
8.16%
Pengembalian Ekuitas TTM
19.79%
Pendapatan Per Saham TTM
35.467
Pertumbuhan Pendapatan Kuartalan YOY
7.20%
Eps TTM yang diencerkan
4.97
Pertumbuhan Pendapatan Kuartalan YOY
33.60%
tertinggal PE
28.55
Maju PE
15
Harga Jual TTM
4.0009
Buku Harga MRQ
5.3602
Pendapatan Nilai Perusahaan
4
EBITDA Nilai Perusahaan
15
70.31
5.29%73.17
3.79%798.16
2.89%190.55
1.95%40.23
1.11%118.02
0.98%168.49
0.35%337.00
0.07%114.52
-3.52%317.30
-1.29%